Call us toll-free: 800-878-7828 — Monday - Friday — 8AM - 5PM EST
CMS identifies billing codes for Eli Lilly’s COVID-19 antibody therapy
By Katie Adams for Becker’s Hospital Review CMS published specific codes for billing Medicare for Eli Lilly’s COVID-19 antibody cocktail. The FDA granted emergency use authorization Feb. 9 to the antibody cocktail, a combination of antibodies bamlanivimab and etesevimab. The agency granted emergency use authorization to bamlanivimab Nov. 9. The new approval is based on phase…